ARCTURUS THERAPEUTICS HLDGS shareholders Q2 2023

ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 145 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q2 2023. The put-call ratio across all filers is 1.73 and the average weighting 0.0%.

ARCTURUS THERAPEUTICS HLDGS shareholders Q2 2023
NameSharesValueWeighting ↓
Green Alpha Advisors, LLC 23,820$683,1580.45%
Nikko Asset Management Americas, Inc. 1,404,932$40,251,3020.42%
Delphia (USA) Inc. 8,287$237,6710.38%
Woodline Partners LP 1,069,814$30,682,2660.36%
ARK Investment Management 1,906,996$54,692,6380.36%
FEDERATED HERMES, INC. 4,778,500$137,047,3800.34%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 10,077$289,0080.33%
Diametric Capital, LP 21,274$610,1380.27%
Corton Capital Inc. 16,074$461,0020.22%
Formidable Asset Management, LLC 14,950$4290.09%
DARK FOREST CAPITAL MANAGEMENT LP 33,904$972,3670.09%
Hennion & Walsh Asset Management, Inc. 45,971$1,3180.08%
Virtus ETF Advisers LLC 3,936$112,8840.07%
Byrne Asset Management LLC 3,500$1000.06%
MGO ONE SEVEN LLC 22,688$650,6920.06%
GLOBEFLEX CAPITAL L P 18,047$517,5880.06%
Koss-Olinger Consulting, LLC 13,975$401,0000.05%
PROFUND ADVISORS LLC 28,608$820,4770.04%
Cambria Investment Management, L.P. 17,155$492,0050.04%
ROYCE & ASSOCIATES LP 129,836$3,723,6960.04%
External links

This page lists ARCTURUS THERAPEUTICS HLDGS's shareholders in Q2 2023. To view ARCTURUS THERAPEUTICS HLDGS's shareholder history, click here.